Endocrine and Metabolic Pathology
Endocrine and metabolic pathology is the branch of systemic pathology concerned with diseases of the hormone-producing glands and of the metabolic pathways those hormones regulate. It studies how disturbances in hormone synthesis, secretion, transport, receptor signalling, and feedback control produce disease, ranging from autoimmune destruction of the pancreatic islets to hormone excess from a functioning tumour or to the metabolic bone loss of osteoporosis.
Definition
Endocrine and metabolic pathology is the study of structural and functional disorders of the endocrine glands and of the metabolic processes under hormonal control, encompassing states of hormone deficiency, hormone excess, hormone resistance, and disrupted regulatory feedback.
Scope
The area orients the reader to disorders of the endocrine system and of intermediary metabolism as studied through the lens of pathology and laboratory medicine. It groups the principal clinical entities covered in this subtree, including type 1 and type 2 diabetes mellitus, thyroid disease, osteoporosis, and adrenal insufficiency, and frames the common mechanisms (hormone excess, deficiency, resistance, and dysregulated feedback) that connect them. It is a reference and educational overview, not clinical guidance.
Sub-topics
Key concepts
- Hormone deficiency versus hormone excess
- Hormone resistance
- Negative feedback and the hypothalamic-pituitary axes
- Autoimmune endocrine destruction
- Functioning and non-functioning endocrine tumours
- Primary versus secondary endocrine disorder
- Metabolic homeostasis and its failure
Mechanisms
Endocrine disease arises when the normal loop of hormone synthesis, secretion, target-tissue action, and feedback inhibition is broken. Glands may be destroyed (autoimmune, infectious, infiltrative, or ischaemic), leading to hormone deficiency; they may secrete autonomously (adenoma, hyperplasia, or carcinoma), leading to hormone excess; or target tissues may fail to respond, producing hormone resistance despite adequate or elevated hormone levels. A disorder is termed primary when the gland itself is at fault and secondary when the defect lies in the upstream pituitary or hypothalamic signal. Metabolic pathology extends this logic to the downstream pathways, where defective regulation of glucose, lipid, mineral, or bone metabolism produces disease even when a single hormone is not solely responsible.
Clinical relevance
Endocrine and metabolic disorders are among the most common chronic diseases and are central to laboratory medicine, since most are defined and monitored by biochemical measurement of hormones, substrates, and antibodies. This entry describes how such disorders are conceptualised and classified for educational reference; it is not a guide to diagnosis or treatment of any individual.
Epidemiology
Diabetes mellitus and thyroid disease are among the most prevalent endocrine conditions worldwide, and osteoporosis is a major cause of fracture in ageing populations; adrenal insufficiency is comparatively rare but clinically important because untreated it can be life-threatening. Collectively these conditions contribute substantially to the global burden of non-communicable disease.
Evidence & guidelines
Each clinical entity in this subtree is supported by disease-specific reviews and by professional-society guidance from bodies such as the American Diabetes Association, the European Association for the Study of Diabetes, the American Thyroid Association, and the Endocrine Society; the individual topic entries cite these sources. General pathophysiology follows standard pathology texts.
History
The understanding of endocrine disease developed alongside the concept of internal secretion in the late nineteenth and early twentieth centuries, with the isolation of insulin in the 1920s as a landmark that transformed diabetes from a fatal to a manageable disorder. The subsequent identification of autoimmune mechanisms, hormone receptors, and feedback regulation built the modern framework within which endocrine and metabolic pathology is taught.
Related topics
Seminal works
- katsarou-2017
- defronzo-2015
- compston-2019
- charmandari-2014
Frequently asked questions
- What distinguishes a primary from a secondary endocrine disorder?
- A primary disorder originates in the target endocrine gland itself, whereas a secondary disorder results from an abnormal upstream signal, typically from the pituitary or hypothalamus, that drives or fails to drive the gland.
- How does hormone resistance differ from hormone deficiency?
- In hormone deficiency the gland produces too little hormone, while in hormone resistance the hormone is present in normal or raised amounts but target tissues respond poorly to it, as classically seen in type 2 diabetes mellitus.